Therapeutic Solutions International, Inc.
TSOI
$0.0001
$0.000.00%
OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.50% | -8.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.50% | -8.26% | |||
| Cost of Revenue | -34.33% | -10.67% | |||
| Gross Profit | 15.04% | -6.99% | |||
| SG&A Expenses | 390.04% | -36.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 366.79% | -39.00% | |||
| Operating Income | -385.02% | 39.99% | |||
| Income Before Tax | -339.04% | 39.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -338.29% | 39.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1,283.45% | -58.51% | |||
| Net Income | -158.33% | 33.34% | |||
| EBIT | -385.02% | 39.99% | |||
| EBITDA | -475.54% | 45.15% | |||
| EPS Basic | -100.00% | 0.00% | |||
| Normalized Basic EPS | -- | 100.00% | |||
| EPS Diluted | -100.00% | 0.00% | |||
| Normalized Diluted EPS | -- | 100.00% | |||
| Average Basic Shares Outstanding | 8.89% | 14.12% | |||
| Average Diluted Shares Outstanding | 8.89% | 14.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||